Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP

E. Rabe*, F. X. Breu, I. Flessenkämper, H. Gerlach, S. Guggenbichler, B. Kahle, R. Murena, S. Reich-Schupke, T. Schwarz, M. Stücker, E. Valesky, S. Werth, F. Pannier

*Corresponding author for this work

Abstract

These guidelines are also consistent with the results of the first European guidelines for sclerotherapy dating from 2012 [1]. These guidelines consider the current state of the literature, but not in every case the different conditions of approval of the various drugs.
Translated title of the contributionLeitlinie Sklerosierungsbehandlung der Varikose: S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP. Englische Version
Original languageEnglish
JournalHautarzt
ISSN0017-8470
DOIs
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'Sclerotherapy in the treatment of varicose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP'. Together they form a unique fingerprint.

Cite this